Literaturangaben

Zeitschrift für Infektionstherapie 1.2024

 

 

Aktuelle Epidemiologie und Diagnostik in der Mikrobiologie

Reiseimpfungen: Influenza – das Stiefkind der Reisemedizin? (S. 2)

1.    Forschungsgemeinschaft Urlaub und Reisen. https://www.rnd.de/reise/reisen-2023-deutsche-planen-65-millionen-urlaubsreisen-reiselust-trotz-inflation-auf-vor-corona-3N7N23YJPVBXFFLZD4JVBCQUAE.html


2.    Ziegler CC. Travel-related illness. Crit Care Nurse Clin North Am 2013; 25(2): 333-340. doi: 10.1016/j.ccell.2013.02.015.


3.    Ratnam I, Black J, Leder K, Biggs BA, Gordon I, Matchett E, Padiglione A, Woolley I, Karapanagiotidis T, Gherardin T, Demont C, Luxemburger C, Torresi J. Incidence and risk factors for acute respiratory illnesses and influenza virus infections in Australian travellers to Asia. J Clin Virol 2013; 57(1): 54-58. doi: 10.1016/j.jcv.2013.01.008.


4.    Belderok SM, Rimmelzwaan GF, van den Hoek A, Sonder GJB. Effect of travel on influenza epidemiology. Emerg Infect Dis 2013; 19(6): 925-931. doi: 10.3201/eid1906.111864.


5.    Steffen R. Travel vaccine preventable diseases—updated logarithmic scale with monthly incidence rates. J Travel Med 2018; 25(1). doi: 10.1093/jtm/tay046.


6.    Grobusch MP, Weld L, Goorhuis A, Hamer DH, Schunk  M, Jordan S, Mockenhaupt FP, Chappuis F, Asgeirsson H, Caumes E, Jensenius M, van Genderen PJJ, Castelli  F, López-Velez R, Field V, Bottieau E, Molina I, Rapp C, Díaz Ménendez M, Gkrania-Klotsas E, Larsen CS, Malvy D, Lalloo D, Gobbi F, Florescu SA, Gautret P, Schlagenhauf P, EuroTravNet. Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data. Lancet Reg Health Eur 2020; 1: 100001. doi: 10.1016/j.lanepe.2020.100001.


7.    Goeijenbier M, van Genderen P, Ward BJ, Wilder-Smith A, Steffen R, Osterhaus ADME. Travellers and influenza: risks and prevention. J Travel Med 2017; 24(1): taw078. doi: 10.1093/jtm/taw078.


8.    Ständige Impfkommission: Empfehlungen der Ständigen Impfkommission (STIKO) beim Robert Koch-Institut 2023. Epidem Bull 2023; 4: 3-68. doi: 10.25646/10829.4.


9.    Honce R, Schultz-Cherry S. Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness. J Travel Med 2019; 26(3): taz020. doi: 10.1093/jtm/taz020.


10.    Robert Koch Institut. https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Influenza_saisonal.html


11.    Newman LP, Bhat N, Fleming JA, Neuzil KM. Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016. PLoS One 2018; 13(2): e0193263. doi: 10.1371/journal.pone.0193263.


12.    Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED, Greenaway CA, Lim PL, Schwartz E, Wilder-Smith A, Wilson ME, GeoSentinel Surveillance Network. Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network. Vaccine 2010; 28(46): 7389-7395. doi: 10.1016/j.vaccine.2010.09.009.


13.    Chen LH, Leder K, Wilson ME. Business travelers: vaccination considerations for this population. Expert Rev Vaccines 2013; 12(4): 453-466. doi: 10.1586/erv.13.16.


14.    Kak V. Infections on cruise ships. Microbiol Spetr 2015; 3(4). doi: 10.1128/microbiolspec.IOL5-0007-2015.


15.    Millman AJ, Kornylo Duong K, Lafond K, Green NM, Lippold SA, Jhung MA. Influenza outbreaks among passengers and crew on two cruise ships: a recent account of preparedness and response to an ever-present challenge. J Travel Med 2015; 22(5): 306-311. doi: 10.1111/jtm.12215.


16.    Aoki Y, Amaya Dimas LDC. Influenza epidemic on a world cruise ship: a descriptive study. Travel Med Infect Dis 2021; 44: 102176. doi: 10.1016/j.tmaid.2021.102176.


17.    Balkhy HH, Memish ZA, Bafaqeer S, MA Almuneef. Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Travel Med 2004; 11(2): 82-86. doi: 10.2310/7060.2004.17027.


18.    Alfelali M, Barasheed O, Tashani M, Azeem MI, El Bashir H, Memish ZA, Heron L, Khandaker G, Booy R, Rashid H, Hajj Research Team. Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: a 10-year retrospective analysis of data. Vaccine 2015; 33(22): 2562-2569. doi: 10.1016/j.vaccine.2015.04.006.


19.    Safarpour H, Safi-Keykaleh M, Farahi-Ashtiani I, Bazyar J, Daliri S, Sahebi A. Prevalence of influenza smong Hajj pilgrims: a systematic review and meta-analysis. Diseaster Med Public Health Prep 2022; 16(3): 1221-1228. doi: 10.1017/dmp.2020.472.


20.    Alfelali M, Barasheed O, Badahdah AM, Bokhary H, Azeem MI, Habeebullah T, Bakarman M, Asghar A, Booy R, Rashid H, Hajj Research Team. Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriers. Vaccine 2018; 36(16): 2112-2118. doi: 10.1016/j.vaccine.2018.03.007.


21.    Robert Koch Institut. Ergebnisbericht 2023: OKaPII - Onlinebefragung von Klinikpersonal zur Influenza-Impfung (22.08.2023). https://www.rki.de/DE/Content/Infekt/Impfen/Forschungsprojekte/OKaPII/Ergebnisbericht_2023.pdf


22.    Brehm TT, Jordan S, Addo MM, Ramharter M, Kreuels  B. Attitudes, practices, and obstacles towards influenza vaccination for international travelers among travel health advisors in Germany: a questionnaire-based survey. Travel Med Infect Dis 2022; 45: 102233. doi: 10.1016/j.tmaid.2021.102233.

Jetzt für den INFEKTIO letter anmelden und regelmäßig per E-Mail Wissenswertes aus Mikrobiologie, Arznei-mittelforschung,Therapie uvm. erhalten.

Informationen für Ärzte und Apotheker zur rationalen Infektionstherapie

Die Zeitschrift für Infektionstherapie (bis 2015: "Zeitschrift für Chemotherapie") erscheint im Jahr 2024 im 45. Jahrgang. Herausgeber und Redaktion sind bemüht, Sie kontinuierlich und aktuell über wichtige Entwicklungen im Bereich der Infektionstherapie zu informieren.

Druckversion | Sitemap
© mhp Verlag GmbH 2023